Clauss matthias (61 resultados)

Condición: As New. Unread book in perfect condition.

Condición: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: New. In English.

2005th ed. 17 x 24 cm. 338 pages. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: New. In English.

Condición: Gebraucht - Gut. original Heft, nicht paginiert, 28 Seiten, diverse Abbildungen, beiliegende Besetzungsliste. Zustand: gut Ein Lustspiel. Inszenierung: Thomas Bischoff. Bühne und Kostüme: Uta Kala. Mitwirkende: Peter bernhardt, Tim Ben Schöfer, Hannsjörg Schuster, Christine Häussler, Bettina Buchholz, u.a. ------- Program booklet for Kleist's THE BROKEN JUG, Theater Heidelberg 1996 - Original booklet, unpaginated, 28 pages, various illustrations, cast list included. Condition: good - A comedy. Directed by Thomas Bischoff. Set and costume design by Uta Kala. Cast: Peter Bernhardt, Tim Ben Schöfer, Hannsjörg Schuster, Christine Häussler, Bettina Buchholz, and others. deu. …

Condición: Gebraucht - Gut. original Heft, 13 Seiten, einige Abbildungen. Zustand: gut Schauspiel in zwei Akten. Inszenierung: Olga Sawitzki. Darsteller: Ulrike Requardt, Michael Wenninger, Jan Pröhl, Luise Poustka ------- Program booklet Patrick Marber Hautnah Theater Heidelberg 1998 - Original booklet, 13 pages, some illustrations. Condition: good - A play in two acts. Directed by Olga Sawitzki. Starring: Ulrike Requardt, Michael Wenninger, Jan Pröhl, Luise Poustka deu.…

Condición: As New. Unread book in perfect condition.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: New.

Hardcover. Condición: New. In shrink wrap. Looks like an interesting title.

Hardcover. Condición: New. In shrink wrap. Looks like an interesting title.

Hardback. Condición: New. 1.

Condición: New. pp. 340.

Condición: Sehr gut. Zustand: Sehr gut | Seiten: 340 | Sprache: Englisch | Produktart: Bücher | Is it advisable to go back from bedside to the bench? During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed physicians dealing with diseases in which angiogenesis is either exaggerated (as in tumors) or too slow (as in ischemic diseases of heart and brain). Not surprisingly, pro- and antiangiogenic strategies have found their way into clinical trials. For instance, for the USA, the NIH website in early 2004 displayed 38 clinical studies involving either pro- or antiangiogenic th- apies. Given the expected overwhelming wealth of clinical data, the question may be asked whether further exploration of biological mechanisms is required or whether results from the bedside are instructive enough to proceed. This question depends also on the progress of pro- and antiangiogenic clinical trials. In the following, I give a short overview about some of the progress that has been made in this field. Since Judah Folkman proposed antiangiogenic tumor therapy thirty years ago, it has become increasingly evident that agents which interfere with blood vessel formation also block tumor progression. Accordingly, antiangiogenic therapy has gained much attention as a potential adjunct to conventional c- cer therapy.…

Condición: New. pp. 340 Illus.

Condición: New. pp. 340.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New. In English.

Condición: New. The induction of blood vessel growth can be either exaggerated, such as in tumors, or too slow, as in ischemic diseases of heart and brain. This volume looks at our knowledge of factors and principles involved in angiogenic processes, proceeding from a "macroscopic " perspective through cellular and physical mechanisms to the molecular level. Editor(s): Clauss, Matthias; Breier, Georg. Series: Experientia Supplementum. Num Pages: 338 pages, biography. BIC Classification: MFG; MJD. Category: (G) General (US: Trade); (P) Professional & Vocational. Dimension: 244 x 170 x 23. Weight in Grams: 765. . 2004. Hardback. . . . .…

Gebunden. Condición: New. A concise compilation of current knowledge on angiogenesisPresents new targets for medical interventionProvides insight into molecular mechanisms of blood vessel growthIs it advisable to go back from bedside to the bench? During the.

Hardcover. Condición: Brand New. 1st edition. 307 pages. German language. 9.00x6.75x0.75 inches. In Stock.

Condición: New. The induction of blood vessel growth can be either exaggerated, such as in tumors, or too slow, as in ischemic diseases of heart and brain. This volume looks at our knowledge of factors and principles involved in angiogenic processes, proceeding from a "macroscopic " perspective through cellular and physical mechanisms to the molecular level. Editor(s): Clauss, Matthias; Breier, Georg. Series: Experientia Supplementum. Num Pages: 338 pages, biography. BIC Classification: MFG; MJD. Category: (G) General (US: Trade); (P) Professional & Vocational. Dimension: 244 x 170 x 23. Weight in Grams: 765. . 2004. Hardback. . . . . Books ship from the US and Ireland.…

Buch. Condición: Neu. Neuware - Is it advisable to go back from bedside to the bench During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed physicians dealing with diseases in which angiogenesis is either exaggerated (as in tumors) or too slow (as in ischemic diseases of heart and brain). Not surprisingly, pro- and antiangiogenic strategies have found their way into clinical trials. For instance, for the USA, the NIH website in early 2004 displayed 38 clinical studies involving either pro- or antiangiogenic th- apies. Given the expected overwhelming wealth of clinical data, the question may be asked whether further exploration of biological mechanisms is required or whether results from the bedside are instructive enough to proceed. This question depends also on the progress of pro- and antiangiogenic clinical trials. In the following, I give a short overview about some of the progress that has been made in this field. Since Judah Folkman proposed antiangiogenic tumor therapy thirty years ago, it has become increasingly evident that agents which interfere with blood vessel formation also block tumor progression. Accordingly, antiangiogenic therapy has gained much attention as a potential adjunct to conventional c- cer therapy.…